Article
Commission asks Tribunal to prosecute Roche for alleged excessive pricing of breast cancer treatment drug
Rating:
0.0
Views:
52
Likes:
1
Library:
1
The Competition Commission on February 8 filed a referral with the Competition Tribunal for prosecution of Switzerland-based multinational healthcare company Roche Holding and its subsidiaries F Hoffman La Roche AG (Roche Basel) and Roche Products (Roche SA) for alleged excessive pricing of a breast cancer treatment drug, Trastuzumab, in contravention of Sections 8(a) and 8(1)(a) of the Competition Act.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value